Reconsidering the Polycystic Ovary Syndrome (PCOS)

The study re-evaluated Polycystic Ovary Syndrome (PCOS), focusing on the lean phenotype D, which was often misclassified due to its transition from hyperandrogenism in early adulthood to hypoandrogenism after age 35. This transition led to resistance to infertility treatments, which could be reversed with androgen supplementation. The research proposed redefining PCOS into two categories: H-PCOS (hyperandrogenic) and HH-PCOS (hyper-/hypoandrogenic), with phenotype D in the latter. The study involved 154 HH-PCOS patients and 126 controls, finding that androgen supplementation improved IVF outcomes for HH-PCOS patients. It emphasized the need for age-specific diagnoses and suggested that PCOS might represent two distinct conditions, highlighting the importance of differentiating subtypes for better diagnosis and treatment.